Travere Therapeutics (TVTX) Announces Late-Breaking Data from Phase 3 Studies of Sparsentan in IgAN and FSGS Published in The Lancet and The NEJM streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The National Institutes of Health has awarded The Ohio State University Center for Clinical and Translational Science (CCTS) a five-year $1.5 million grant to fund graduate student training in clinical and translational research.
Results from a confirmatory study evaluating sparsentan in patients with primary IgAN showed that the treatment was associated with kidney function preservation.
Thank you to our growing list of partners who helped to enhance and expand the show during a year that brought new focus on EVs, in-vehicle technologies and expanded content and consumer education. Dozens of sponsors provided innovative exhibits and displays, most notably the AutoMobili-D technology showcase which expanded to 90,000 sq. ft. on the main show floor featuring 51 technology companies and more than 140 startups. Air Mobility displays continued to be a unique show feature. Educ.